| ISIN | CH0034334737 |
|---|---|
| Valor Number | 3433473 |
| Bloomberg Global ID | BBG000VD7YS4 |
| Fund Name | Bellevue Medtech & Services AA CHF |
| Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
| Fund Provider | Bellevue Asset Management AG |
| Representative in Switzerland | |
| Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | Special conditions apply to the issue of units |
| Redemption Condition | Special conditions apply to the redemption of units |
| Investment Strategy *** | n.a. |
| Peculiarities |
| Current Price * | 2,977.97 CHF | 20.01.2026 |
|---|---|---|
| Previous Price * | 3,032.55 CHF | 16.01.2026 |
| 52 Week High * | 3,853.28 CHF | 03.02.2025 |
| 52 Week Low * | 2,782.30 CHF | 06.08.2025 |
| NAV * | 2,977.97 CHF | 20.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 52,711,081 | |
| Unit/Share Assets *** | 12,744,756 | |
| Trading Information SIX | ||
| YTD Performance | -0.25% |
31.12.2025 - 20.01.2026
31.12.2025 20.01.2026 |
|---|---|---|
| 1 month | -0.81% |
22.12.2025 - 20.01.2026
22.12.2025 20.01.2026 |
| 3 months | -1.73% |
20.10.2025 - 20.01.2026
20.10.2025 20.01.2026 |
| 6 months | +5.91% |
21.07.2025 - 20.01.2026
21.07.2025 20.01.2026 |
| 1 year | -20.10% |
21.01.2025 - 20.01.2026
21.01.2025 20.01.2026 |
| 2 years | -10.81% |
22.01.2024 - 20.01.2026
22.01.2024 20.01.2026 |
| 3 years | -14.48% |
20.01.2023 - 20.01.2026
20.01.2023 20.01.2026 |
| 5 years | -12.29% |
20.01.2021 - 20.01.2026
20.01.2021 20.01.2026 |
| Equity Participation Rate in % | 99.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | 20.1706 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | 20.01.2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UnitedHealth Group Inc | 14.25% | |
|---|---|---|
| Abbott Laboratories | 10.88% | |
| Intuitive Surgical Inc | 10.03% | |
| Boston Scientific Corp | 7.86% | |
| Stryker Corp | 7.04% | |
| Medtronic PLC | 5.88% | |
| McKesson Corp | 4.92% | |
| Essilorluxottica | 4.79% | |
| CVS Health Corp | 4.41% | |
| HCA Healthcare Inc | 4.13% | |
| Last data update | 30.11.2025 | |
| TER | 1.85% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | 10.00% |
| PTR | |
| Max. Management Fee *** | 2.00% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |